← Back to list
Homocysteine Testing (CPB 0763, reviewed 2026-10-28)
Effective date
Not stated in the notice
Identified
Oct 30, 2026
Summary
Aetna clinical policy bulletin CPB 0763 covers homocysteine testing and was last reviewed 10/28/2026. It lists the indications Aetna considers medically necessary, including CPT 83090 and the covered ICD-10 codes listed in the bulletin, and it states that Aetna considers homocysteine testing experimental, investigational, or unproven for all other indications. The source text does not describe what changed in this review.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
Get Aetna alertsPolicy Monitoring is free. No card required.
What to do
Action · 2 steps
01Read the full policy at the source link to see what changed.
02The bulletin lists the indications Aetna considers medically necessary for homocysteine testing.
Codes mentioned
83090D81.818D81.819E53.8I81
Original notice
Homocysteine Testing (CPB 0763, reviewed 2026-10-28)
aetna.com · Always check the source before changing claims.
Related changes
See all Aetna changes →Homocysteine Testing (CPB 0763, reviewed 2025-11-12)MediumNo effective date · Medical PolicyVitamin B-12 Therapy (CPB 0536, reviewed 2026-08-20)MediumNo effective date · Medical PolicyVitamin B-12 Therapy (CPB 0536, reviewed 2025-08-21)MediumNo effective date · Medical PolicyBiochemical Markers of Bone Remodeling (CPB 0562, reviewed 2026-08-21)MediumNo effective date · Medical PolicyBrowse every Aetna change in the policy list